Efficacy of Dichlorophenolindophenol (DCIP) as Screening Test for Hb E: Revisited

  • Prakas Kumar Mandal
  • K. S. Nataraj
  • Shuvra Neel BaulEmail author
  • Malay Kumar Ghosh
  • Tuphan Kanti Dolai
Original Article


Hb E-beta thalassemia is a major public health problem in West Bengal, India and is the predominant symptom producing thalassemia in this part of the country. To search for an easy, reliable and cost effective screening method for HbE that can be used at the community level where more sophisticated methods are not readily available. And the DCIP test was performed for the purpose. Blood samples of 425 asymptomatic family members from 80 diagnosed cases of HbE beta Thalassemia patients were tested for Hb, RBC indices, DCIP test, HPLC, and in discordant cases confirmed by DNA mutation analysis. The present study shows DCIP screening test to have a sensitivity, specificity, positive predictive value and negative predictive value of 96.39%, 97.43%, 96.39% and 97.43% respectively. It also shows a false positive rate and false negative rate in 2.56% and 4.6% cases respectively. The advantage with DCIP over HPLC is that it can be easily performed at the community level by a person with minimum technical skill, few samples (even a single sample) can be tested at time, at a low cost.


Hemoglobin E Screening test HPLC DCIP 




Compliance with Ethical Standards

Conflict of interest

The authors declare no potential conflicts of interest.

Ethical Approval

The study was approved by the Institutional Ethical Committee (IEC).

Patient Consent

Written consent taken from each patient and/or their legal guardians at the entry into the study.


  1. 1.
    Bain BJ (2006) Other significant hemoglobinopathies. In: Hemoglobinopathy diagnosis, vol 2/e, Blackwell Publishing, pp 191–213Google Scholar
  2. 2.
    Bain BJ, Wild BJ, Stephens AD, Phelan LA (2010) Common hemoglobins of major clinical importance. In: Variant hemoglobin’s: a guide to identification, vol 1/e, Wiley-Blackwell, Oxford, pp 41–45Google Scholar
  3. 3.
    Kulapongs P, Sanguansermsri T, Mertz G, Tawarat S (1976) Dichlorophenolindophenol (DCIP) precipitation test: a new screening test for Hb E and H. Pediatr Soc Thail 15:1–7Google Scholar
  4. 4.
    Fucharoen G, Sanchaisuriya K, Sae-ung N, Dangwibul S, Fucharoen S (2004) A simplified screening strategy for thalassaemia and haemoglobin E in rural communities in Southeast Asia. Bull World Health Organ 82:364–372PubMedPubMedCentralGoogle Scholar
  5. 5.
    Carrel RW, Kay R (1972) A simple method for the detection of unstable hemoglobins. Br J Hematol 23:615–619. CrossRefGoogle Scholar
  6. 6.
    Elles R, Old JM (1987) Laboratory procedures for DNA analysis. In: WHO training course in standard techniques and advances methodologies for the control of hereditary anemias. WHO, Herakleon, Greece, p 5Google Scholar
  7. 7.
    Newton CR, Graham A, Hiptinstall LE et al (1989) Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucl Acid Res 17:2503–2516CrossRefGoogle Scholar
  8. 8.
    Chernoff AL, Minnich V, Chongchareonsuk S (1954) Hemoglobin E, a hereditary abnormality of human hemoglobin. Science 120:605–606CrossRefGoogle Scholar
  9. 9.
    Itano HA, Bergren WR, Sturgeon P (1954) Identification of a fourth abnormal hemoglobin. J Am Chem Soc 76:2278CrossRefGoogle Scholar
  10. 10.
    Chatterjea JB, Saha AK, Ray RN et al (1956) Electrophoretic analysis of haemoglobin in Cooley’s anaemia (thalassemia). Evidences of interaction of thalassemia gene with abnormal hemoglobin. Bull Calcutta Sch Trop Med 4:103–105Google Scholar
  11. 11.
    National task force study on Thalassemia-2005 (2008) Jai Vigyan S&T Mission project on community control of thalassemia syndromes: awareness, screening, genetic counseling and prevention, Indian Council of Medical Research (ICMR), New Delhi, p 21Google Scholar
  12. 12.
    Sanchaisuriya K, Fucharoen S, Fucharoen G, Ratanasiri T, Sanchaisuriya P, Changtrakul Y et al (2005) A reliable screening protocol for thalassemia and hemoglobinopathies in pregnancy; an alternative approach to electronic blood cell counting. Am J Clin Pathol 123:113–118CrossRefGoogle Scholar
  13. 13.
    Chandrashekar V, Soni M (2011) Hemoglobin disorders in South India. ISRN Hematol 2011:1–6CrossRefGoogle Scholar
  14. 14.
    Vichinsky E (2007) Hemoglobin e syndromes. Hematol Am Soc Hematol Educ Progr 2007:79–83CrossRefGoogle Scholar
  15. 15.
    Sanchaisuriya K, Fucharoen G, Sae-ung N, Sae-un N, Baisungneon R, Jetsrisuparb A, Fucharoen S (1997) Molecular and hematological characterization of HbE heterozygotes with alpha-thalassemia determinant. Southeast Asian J Trop Med Public Health 28:100–103PubMedGoogle Scholar
  16. 16.
    Balgir RS (1996) Genetic epidemiology of the three predominant abnormal hemoglobins in India. J Assoc Phys India 25:44–48Google Scholar
  17. 17.
    Tyagi S, Saxena R, Choudhry VP (2003) HPLC: how necessary is it for haemoglobinopathy diagnosis in India? Indian J Pathol Microbiol 46:390–393PubMedGoogle Scholar
  18. 18.
    Chapple L, Harris A, Phelan L, Bain BJ (2006) Reassessment of a simple chemical method using DCIP for screening for haemoglobin E. J Clin Pathol 59:74–76CrossRefGoogle Scholar
  19. 19.
    Prayongratana K, Polprasert C, Raungrongmorakot K, Tatone K, Santiwatanakul S (2008) Low cost combination of DCIP and MCV was better than that of DCIP and OF in the screening for hemoglobin E. J Med Assoc Thail 91:1499–1504Google Scholar
  20. 20.
    Jaiwang P, Meemungthum I, Wiwanitkit V (2007) Positive DCIP rates: a study on its incidence in laboratory. Chula Med J 51:101–104Google Scholar
  21. 21.
    Wilson JMG, Jungner G (1968) Principles and practice for screening for disease, WHO, Geneva, Pub Hlth Paper No. 34Google Scholar
  22. 22.
    Cochrane AL, Holland WW (1971) Validation of screening procedures. Br Med Bull 27:3–8CrossRefGoogle Scholar

Copyright information

© Indian Society of Hematology and Blood Transfusion 2019

Authors and Affiliations

  1. 1.Department of HematologyCSTM and NRS Medical CollegeKolkataIndia
  2. 2.KolkataIndia
  3. 3.Mazumdar Shaw Cancer CenterNarayana HealthBengaluruIndia
  4. 4.Department of HematologyNRS Medical CollegeKolkataIndia

Personalised recommendations